The first patient with SCD has been dosed in a clinical trial of HBI-002, an experimental, low-dose liquid formulation of ...

Because sickle cell disease is a multisystemic disorder, it can result in a wide range of symptoms, explains columnist.

A student at Kennesaw State is helping develop a low-cost, light-based device to screen for stroke in children with sickle ...

Acute chest syndrome associated with sickle cell is driven by the abnormal activation of the complement cascade, per a study.

Intranasal fentanyl is a feasible, safe, and effective option for managing acute pain episodes in adults with sickle cell ...

With the Cell and Gene Therapy (CGT) Access Model, states will be reimbursed if cell and gene therapies don't benefit sickle cell patients.

Columnist Oluwatosin Adesoye, a doctor, sorts through the difference between sickle cell anemia and sickle cell disease — and ...

The gene-editing therapy OTQ923 normalized brain blood flow in 3 sickle cell disease patients, suggesting it may lower stroke risk, a study says.

The first healthy volunteer has been dosed in a Phase 1 study of Cellarity's novel globin-switching therapy CLY-124 for sickle cell disease.

Higher pain scores upon discharge from the emergency department may predict hospitalization in adolescents with SCD, a study found.

My caregiving journey began with caring for my cousin, a vibrant, witty, and spirited soul whose strength never ceases to amaze me. Along this journey, I’ve learned more than I ever thought possible ...